Letter: proton pump inhibitor treatment and increased mortality in cirrhotic patients

E-ISSN： 1365-2036|41|11|1224-1224

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.11, 2015-06, pp. : 1224-1224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter: proton pump inhibitor treatment and increased mortality in cirrhotic patients – authors' reply

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 11, 2015-06 ,pp. : 1225-1225

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 459-466

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment with proton pump inhibitors is associated with increased mortality in patients with pyogenic liver abscess

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 6, 2018-03 ,pp. : 801-808

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: proton pump inhibitors ‐ severity of liver disease and mortality in patients with cirrhosis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 704-705

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: proton pump inhibitor use and fracture risk

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 449-450

John Wiley & Sons Inc

Access to resources Recommend Favorite